Lucy Carter
Research Assistant and PhD Student
Lucy graduated from the University of Queensland in 2000 with Honours in Philosophy in the area of applied ethics. Since then she has worked as a Research Assistant on various projects in applied ethics both at UQ and Griffith University. She has been a sitting member on the University’s Ethical Review Committee since 1999 and currently divides her time between OPPE and her doctoral studies in bioethics.
Lucy began her PhD in February 2004. She is jointly funded by the ARC Centre of Excellence for Integrative Legume Research (CILR) and the Faculty of Arts at the University of Queensland. Her thesis concerns public and academic debates about GM foods and includes a discussion of the potential risks and benefits of GM crops to third world countries, the introduction of nutraceutical and biopharmaceutical products and the impact of GM crops on the environment. To find out more about this project click here.
Research Interests
Lucy’s research interests include exploring ethical issues raised by:
- Human and animal genetic engineering
- Medical ethics and the doctor-patient relationship
- Participation of vulnerable populations in research
- Environmental philosophy
Contact Details
Phone: 3346 2156
Email: l.carter@imb.uq.edu.au
Publications
Carter L. (2004) Consequentialist objections to transgenesis: GM foods, xenotransplantion and germ line gene therapy, Transgenic Research, in press.
Hall, W. & Carter L. (2004) Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence, Journal of Medical Ethics, 30: 337-340.
Hall, W., Carter, L. & Morley K.I. (2004) Neuroscience research on the addictions: A prospectus for future ethical and policy analysis. Addictive Behaviors, 29 (7): 1481-95.
Morley, K.I., Hall, W.D. & Carter, L. (2004) Genetic screening for susceptibility to depression: can we and should we? Australian and New Zealand Journal of Psychiatry, 38 (1-2): 73-80.
Hall, W., Morley,
K. I. & Carter, L. (2003) Genetics and depression: ethical and policy
implications. In Breaking the Code: 2002 Symposium, Occasional Paper No.
5 (Melbourne: Centre for Law and Genetics).
Hall, W., Carter, L.
& Morley, K.I. (2003) Addiction, ethics and scientific freedom. Addiction,
98(7): 873-874.
Hall, W., Carter, L. & Morley, K.I. (2003) Addiction, neuroscience and ethics. Addiction, 98(7): 867-870.
Morley, K.I., Carter, L. & Hall, W. (2003) Regulation of embryonic stem cell research and therapeutic cloning: The Australian debate. Plaintiff, 55: 20-23.
Hall, W., Carter, L. & Morley, K.I. (2002) Ethical implications of advances in neuroscience research on the addictions. National Drug and Alcohol Research Centre Technical Report No.143, Sydney: National Drug and Alcohol Research Centre.
Carter L. (2002) The ethics of germ line gene modification - A five dimensional debate. Monash Bioethics Review, 21(4): 66-81.
Hall, W. & Carter L. (2002) Ethical issues in trialling and using a cocaine vaccine to treat and prevent cocaine dependence. National Drug and Alcohol Research Centre Technical Report No.141, Sydney: National Drug and Alcohol Research Centre.
Hall W. & Carter L. (2001) Ethical issues in risk management. Geneva: World Health Organization. Background paper for the World Health Report 2002.
Contact webmaster: oppe@uq.edu.au
Last updated 9 September
2004